Abstract:Highlights • Ethoxydiglycol increased the steady-state flux for the cannabinoids. • The CBDA-loaded patch exhibited greater release than the THCA-loaded patch. • The stability of the CLTPs was maintained for at least 90 days at 4 °C. The main active cannabinoids in extracts of Cannabis sativa L., cannabidiolic acid (CBDA) and tetrahydrocannabinolic acid (THCA), are known for their pharmacological effects, including anti-inflammatory, analgesic, psychedelic, anti-cancer, and anti-spasmodic activities. This study aimed to develop adhesive cannabinoid-loaded transdermal patches (CLTPs) to enhance the skin permeation of the active cannabinoids, CBDA and THCA, and evaluate their stability. Optimized CLTPs were prepared in 1.5 % (w/w) polyvinyl alcohol-coated petri dishes using a solvent casting technique. The casting solution consisted of mixtures of isopropyl alcohol and ethanol, along with Eudragit ® E100, succinic acid, dibutyl phthalate, and permeation enhancers such as oleic acid, isopropyl myristate, mixtures of oleic acid and isopropyl myristate, ethoxydiglycol, sesame oil, and co-polymer (Kollidon®VA64). The physicochemical properties of the patches were characterized by uniformity, thickness, drug content, swelling, and mechanical properties. The in vitro release studies of CBDA and THCA through a synthetic hydrophobic membrane using various release enhancers from these patches were conducted using Franz diffusion cells. Using ethoxydiglycol as a release enhancer demonstrated the highest release profile for both cannabinoids. The steady-state flux values of CBDA and THCA were 3.83 ± 0.45 μg/cm 2 /h (1.85-fold compared to the control) and 0.72 ± 0.14 μg/cm 2 /h (1.54-fold compared to the control) at 8 h. The stability studies of CLTPs demonstrated that both remained stable at 4 °C for at least 90 days. In conclusion, transdermal patches containing cannabinoids have been successfully developed and characterized. These findings offer a promising avenue for further investigation of CLTPs, as they could serve as a versatile formulation strategy for pharmaceutical products. Graphical abstract Download : Download high-res image (381KB) Download : Download full-size image

Combined hydroxyphenyl-modified adhesive with the ion-pair strategy for long-lasting delivery of clonidine in single-layer matrix-type patch

Formulation Development and Molecular Mechanism Characterization of Long-Acting Patches of Asenapine for Efficient Delivery by Combining API-ILs Strategy and Controlled-Release Polymers

A New Poly(2-Hydroxy-3-phenoxypropylacrylate, 4-Hydroxybutyl Acrylate, Diethyl Maleate) Membrane Controlled Clonidine Linear Release in the Transdermal Drug Delivery System

A new copolymer membrane cured by 2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, and isobutyl methacrylate controlled clonidine linear release in the transdermal drug delivery system

Combining ion-pair strategy and percutaneous permeation enhancers to develop sustained-release paliperidone patch

Development of levamlodipine long-acting patches based on an ion-pair strategy: Investigation of the mechanism for reducing skin irritation

Combining Ion-Pair Strategy and Chemical Enhancers to Develop Mirtazapine Long-Acting Transdermal Patches for Depression Treatment

Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives

3-Methacryloxypropyltrimethoxysilane-Modified Hydroxyl Acrylate Pressure-Sensitive Adhesive with High Antiplasticity for Efficient Transdermal Drug Delivery

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation

Release Characterization of Drugs in Hot-melt Pressure Sensitive Adhesive

A new copolymer membrane controlling clonidine linear release in a transdermal drug delivery system.

Fe (Iii)-Coordinated N-[Tris(Hydroxymethyl)Methyl]Acrylamide Modified Acrylic Pressure-Sensitive Adhesives with Enhanced Adhesion and Cohesion for Efficient Transdermal Application

Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release.

Improved transdermal delivery of novel cannabinoid-loaded patches using Eudragit matrix

A Novel Hydrophilic Adhesive Matrix with Self-Enhancement for Drug Percutaneous Permeation Through Rat Skin

Design and evaluation of a drug-in-adhesive patch for the transdermal delivery of ketoprofen

In Vitro and in Vivo Characterization of A Newly Developed Clonidine Transdermal Patch for Treatment of Attention Deficit Hyperactivity Disorder in Children

Design and in Vitro Evaluation of Transdermal Patches Based on Ibuprofen-Loaded Electrospun Fiber Mats

Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide

Acrylate Copolymer: a Rate-Controlling Membrane in the Transdermal Drug Delivery System